Opportunity to Invest in Healthcare/ ESG

We’re keeping tabs on some of the exciting offers coming across our desk and one that we wanted to share with you is Bioactive Laboratories, led by a fantastic team of founders with years of experience who found a significant gap in the market:

45% of reproductive age women suffer severe period pain, needing medication every month – amounting to around 1.17B women globally

To enable thousands of customers to go about their daily activities, Bioactive Laboratories have developed Khapregesic®, a fast-acting non-drug alternative to relieve pain: both period pain and pain from associated conditions (Endometriosis & PCOS), with additional observed benefits: sleep quality improvement, anxiety reduction, and an array of PMS symptoms alleviated. The product has generated hundreds of positive customer reviews.

Khapregesic® Pipeline
Clinical evidence and now customer feedback have confirmed many other Khapregesic® applications.

From joint and muscle pain to anxiety, memory and sleep improvement. A complete range has been designed, formulated and is ready to roll-out.

Once the market model of Khapregesic® for Period Pain is established, they can quickly leverage new applications.

Plus, Bioactive Laboratories scientists have discovered an array of other treatments yet to be commercialised. Khapregesic® Pipeline Clinical evidence and now customer feedback have confirmed many other Khapregesic® applications.

Bioactive Laboratories: raising A$2M

  • controls the entire supply chain with IP and trade secrets protection;
  • clinically tested & regulatory approved;
  • 100+ Customers & Resellers, 180k+ Ad reach, 100k+ organic reach per week and growing.

► Register interest in Bioactive Laboratories. Bioactive Laboratories is a carbon positive company, addressing 4 of the UN sustainable development goals: Gender Equality, Biodiversity, Health and Climate Change.

© 2020 KapVista